Canaccord Genuity Assumes Quipt Home Medical at Buy, Announces Price Target of $11
Portfolio Pulse from richadhand@benzinga.com
Canaccord Genuity analyst Richard Close assumes coverage on Quipt Home Medical (NASDAQ:QIPT) with a Buy rating and a price target of $11.
June 14, 2023 | 2:21 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Canaccord Genuity analyst Richard Close initiates coverage on Quipt Home Medical with a Buy rating and a price target of $11.
The Buy rating and $11 price target from Canaccord Genuity analyst Richard Close indicate a positive outlook for Quipt Home Medical. This news is likely to have a positive short-term impact on QIPT's stock price as it shows confidence in the company's potential growth and performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100